Hello, Guest!

Tag: Biomedical Advanced Research and Development Authority

Emergent BioSolutions to Deliver Anthrax Vaccines to National Stockpile Under $100M BARDA ContractContract Awards

Emergent BioSolutions to Deliver Anthrax Vaccines to National Stockpile Under $100M BARDA Contract

Emergent BioSolutions (NYSE: EBS) has received a potential two-year, $100 million contract from the Biomedical Advanced Research and Development Authority to
SRI International Lands 2 BARDA Nonclinical Research Service Contracts Worth $90MContract Awards

SRI International Lands 2 BARDA Nonclinical Research Service Contracts Worth $90M

SRI International has received a pair of contracts worth a combined $90 million to help  the Biomedical Advanced Research and Development
Emergent BioSolutions Gets $199M HHS Funds to Mature Anthrax Vaccine CandidateContract Awards

Emergent BioSolutions Gets $199M HHS Funds to Mature Anthrax Vaccine Candidate

The Department of Health and Human Services has awarded Emergent BioSolutions a five-year, $198.7 million contract to further mature the
Sanofi Pasteur Receives Potential $173.4M HHS Contract to Develop Inactivated Zika VaccineContract Awards

Sanofi Pasteur Receives Potential $173.4M HHS Contract to Develop Inactivated Zika Vaccine

The Department of Health and Human Services has awarded a potential $173.6 million contract to Sanofi Pasteur for work to develop inactivated vaccine
BARDA to Support Altimmune Anthrax Vaccine Clinical Trials Under $120M ContractContract Awards

BARDA to Support Altimmune Anthrax Vaccine Clinical Trials Under $120M Contract

Altimmune has received a potential five-year, $120.2 million contract from the Biomedical Advanced Research and Development Authority to conduct clinical
Emergent BioSolutions Lands BARDA Task Order for Zika Vaccine DevelopmentContract Awards

Emergent BioSolutions Lands BARDA Task Order for Zika Vaccine Development

The Biomedical Advanced Research and Development Authority has awarded Emergent BioSolutions (NYSE: EBS) a potential $21.9 million task order to develop
CDC Awards Emergent BioSolutions New Anthrax Vaccine Development FundsContract Awards

CDC Awards Emergent BioSolutions New Anthrax Vaccine Development Funds

The Department of Health and Human Services has tapped Emergent BioSolutions to further develop a new anthrax vaccine under a 30-month, $31